Retrospective cohort links psychedelic intensity during sublingual ketamine treatment to antidepressant outcomes
A retrospective longitudinal cohort study of 3,637 adults with moderate-to-severe depression reports that higher subjective psychedelic intensity at 2 weeks of sublingual ketamine treatment was associated with greater reductions in depression severity at 4 weeks.